Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Svennerholm, B' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 45 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Su, J; Andersson, E; Horai, P; Naghavi, MH; Palm, A; Wu, YP; Eriksson, K; Jansson, M; Wigzell, H; Svennerholm, B; Vahlne, A
      The nontoxic tripeptide glycyl-prolyl-glycine amide inhibits the replication of human immunodeficiency virus type 1

      JOURNAL OF HUMAN VIROLOGY
    2. Su, J; Naghavi, MH; Jejcic, A; Horal, P; Furuta, Y; Wu, YP; Li, SL; Hall, WW; Goobar-Larsson, L; Svennerholm, B; Vahlne, A
      The tripeptide glycyl-prolyl-glycine amide does not affect the early stepsof the human immunodeficiency virus type 1 replication

      JOURNAL OF HUMAN VIROLOGY
    3. Harandi, AM; Svennerholm, B; Holmgren, J; Eriksson, K
      Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired gamma interferon-mediated protective immunity

      JOURNAL OF VIROLOGY
    4. Harandi, AM; Svennerholm, B; Holmgren, J; Eriksson, K
      Differential roles of B cells and IFN-gamma-secreting CD4(+) T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice

      JOURNAL OF GENERAL VIROLOGY
    5. Andersson, LM; Svennerholm, B; Hagberg, L; Gisslen, M
      Higher HIV-1 RNA cutoff level required in cerebrospinal fluid than in blood to predict positive HIV-1 isolation

      JOURNAL OF MEDICAL VIROLOGY
    6. Liljeqvist, JA; Svennerholm, B; Bergstrom, TS
      Conservation of type-specific B-cell epitopes of glycoprotein G in clinical herpes simplex virus type 2 isolates

      JOURNAL OF CLINICAL MICROBIOLOGY
    7. Gisslen, M; Svennerholm, B; Norkrans, G; Franzen, C; Sall, C; Svensson, R; Obergs, S; Hagberg, L
      Cerebrospinal fluid and plasma viral load in HIV-1-infected patients with various anti-retroviral treatment regimens

      SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
    8. Trybala, E; Liljeqvist, JA; Svennerholm, B; Bergstrom, T
      Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate

      JOURNAL OF VIROLOGY
    9. Gisslen, M; Fuchs, D; Svennerholm, B; Hagberg, L
      Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
    10. Liljeqvist, JA; Svennerholm, B; Bergstrom, T
      Typing of clinical herpes simplex virus type 1 and type 2 isolates with monoclonal antibodies

      JOURNAL OF CLINICAL MICROBIOLOGY
    11. Liljeqvist, JA; Svennerholm, B; Bergstrom, T
      Typing of clinical herpes simplex virus type 1 and type 2 isolates with monoclonal antibodies (vol 37, pg 2717, 1999)

      JOURNAL OF CLINICAL MICROBIOLOGY
    12. Vahlne, A; Bergstrom, T; Svennerholm, B
      Herpes

      VACCINES
    13. Liljeqvist, JA; Svennerholm, B; Bergstrom, T
      Herpes simplex virus type 2 glycoprotein G-negative clinical isolates are generated by single frameshift mutations

      JOURNAL OF VIROLOGY
    14. Andersson, LM; Blennow, K; Fuchs, D; Svennerholm, B; Gisslen, M
      Increased cerebrospinal fluid protein tau concentration in neuro-AIDS

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    15. Losman, B; Biller, M; Olofsson, S; Schonning, K; Lund, OS; Svennerholm, B; Hansen, JES; Bolmstedt, A
      The N-linked glycan of the V3 region of HIV-1 gp120 and CXCR4-dependent multiplication of a human immunodeficiency virus type 1 lymphocyte-tropic variant

      FEBS LETTERS
    16. GISSLEN M; HAGBERG L; FUCHS D; NORKRANS G; SVENNERHOLM B
      CEREBROSPINAL-FLUID VIRAL LOAD IN HIV-1-INFECTED PATIENTS WITHOUT ANTIRETROVIRAL TREATMENT - A LONGITUDINAL STUDY

      Journal of acquired immune deficiency syndromes and human retrovirology
    17. GISSLEN M; NORKRANS G; SVENNERHOLM B; HAGBERG L
      HIV-1 RNA DETECTABLE WITH ULTRASENSITIVE QUANTITATIVE POLYMERASE CHAIN-REACTION IN PLASMA BUT NOT IN CEREBROSPINAL-FLUID DURING COMBINATIONTREATMENT WITH ZIDOVUDINE, LAMIVUDINE AND INDINAVIR

      AIDS
    18. GISSLEN M; SVENNERHOLM B; FUCHS D; HAGBERG L
      NEUROLOGICAL EFFICACY OF STAVUDINE, ZIDOVUDINE, AND LAMIVUDINE

      Lancet
    19. LILJEQVIST JA; TRYBALA E; SVENNERHOLM B; JEANSSON S; SJOGRENJANSSON E; BERGSTROM T
      LOCALIZATION OF TYPE-SPECIFIC EPITOPES OF HERPES-SIMPLEX VIRUS TYPE-2GLYCOPROTEIN-G RECOGNIZED BY HUMAN AND MOUSE ANTIBODIES

      Journal of General Virology
    20. TRYBALA E; BERGSTROM T; SPILLMANN D; SVENNERHOLM B; FLYNN SJ; RYAN P
      INTERACTION BETWEEN PSEUDORABIES VIRUS AND HEPARIN HEPARAN SULFATE - PSEUDORABIES VIRUS MUTANTS DIFFER IN THEIR INTERACTION WITH HEPARIN/HEPARAN SULFATE WHEN ALTERED FOR SPECIFIC GLYCOPROTEIN-C HEPARIN-BINDINGDOMAIN/

      The Journal of biological chemistry
    21. GISSLEN M; HAGBERG L; SVENNERHOLM B; NORKRANS G
      HIV-1 RNA IS NOT DETECTABLE IN THE CEREBROSPINAL-FLUID DURING ANTIRETROVIRAL COMBINATION THERAPY

      AIDS
    22. GISSLEN M; NORKRANS G; SVENNERHOLM B; HAGBERG L
      THE EFFECT ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA LEVELS IN CEREBROSPINAL-FLUID AFTER INITIATION OF ZIDOVUDINE OR DIDANOSINE

      The Journal of infectious diseases
    23. ANDERSSONELLSTROM A; BERGSTROM T; SVENNERHOLM B; MILSOM I
      EPSTEIN-BARR-VIRUS DNA IN THE UTERINE CERVIX OF TEENAGE GIRLS

      Acta obstetricia et gynecologica Scandinavica
    24. BROLIDEN K; VONGEGERFELT A; PERSSON C; HORAL P; SVENNERHOLM B; WAHREN B; BJORLING E; VAHLNE A
      IDENTIFICATION OF CROSS-REACTIVE ANTIGENIC TARGET REGIONS FOR HIV TYPE 1-SPECIFIC ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY

      AIDS research and human retroviruses
    25. LYCKE J; SVENNERHOLM B; HJELMQUIST E; FRISEN L; BADR G; ANDERSSON M; VAHLNE A; ANDERSEN O
      ACYCLOVIR TREATMENT OF RELAPSING-REMITTING MULTIPLE-SCLEROSIS - A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND-STUDY

      Journal of neurology
    26. GISSLEN M; NORKRANS G; SVENNERHOLM B; HAGBERG L
      THE EFFECT ON CEREBROSPINAL-FLUID HIV RNA LEVELS AFTER INITIATION OF ZIDOVUDINE OR DIDANOSINE

      AIDS
    27. TRYBALA E; BERGSTROM T; SPILLMANN D; SVENNERHOLM B; OLOFSSON S; FLYNN SJ; RYAN P
      MODE OF INTERACTION BETWEEN PSEUDORABIES VIRUS AND HEPARAN-SULFATE HEPARIN

      Virology
    28. HAGBERG L; NORKRANS G; GISSLEN M; WACHTER H; FUCHS D; SVENNERHOLM B
      INTRATHECAL IMMUNOACTIVATION IN PATIENTS WITH HIV-1 INFECTION IS REDUCED BY ZIDOVUDINE BUT NOT BY DIDANOSINE

      Scandinavian journal of infectious diseases
    29. CELLO J; STRANNEGARD O; SVENNERHOLM B
      A STUDY OF THE CELLULAR IMMUNE-RESPONSE TO ENTEROVIRUSES IN HUMANS - IDENTIFICATION OF CROSS-REACTIVE T-CELL EPITOPES ON THE STRUCTURAL PROTEINS OF ENTEROVIRUSES

      Journal of General Virology
    30. TRYBALA E; BERGSTROM T; OLOFSSON S; SVENNERHOLM B; JEANSSON S
      AN EVALUATION OF A HEMAGGLUTINATION-INHIBITION TEST FOR THE DETECTIONOF ANTIBODIES TO HERPES-SIMPLEX VIRUS TYPE-1

      Clinical and diagnostic virology
    31. DISTEFANO M; SABRI F; LEITNER T; SVENNERHOLM B; HAGBERG L; NORKRANS G; CHIODI F
      REVERSE-TRANSCRIPTASE SEQUENCE OF PAIRED ISOLATES OF CEREBROSPINAL-FLUID AND BLOOD FROM PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUSTYPE-1 DURING ZIDOVUDINE TREATMENT

      Journal of clinical microbiology
    32. ANDERSSONELLSTROM A; SVENNERHOLM B; FORSSMAN L
      PREVALENCE OF ANTIBODIES TO HERPES-SIMPLEX VIRUS TYPE-1 AND TYPE-2, EPSTEIN-BARR-VIRUS AND CYTOMEGALOVIRUS IN TEENAGE GIRLS

      Scandinavian journal of infectious diseases
    33. BROLIDEN K; VONGEGERFELT A; WAHREN B; HORAL P; SVENNERHOLM B; JEANSSON S; VAHLNE A
      IDENTIFICATION OF ANTIGENIC TARGET REGIONS FOR HIV-1 SPECIFIC ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY

      AIDS research and human retroviruses
    34. LYCKE J; SVENNERHOLM B; SVENNINGSSON A; MURANYI W; FLUGEL RM; ANDERSEN O
      HUMAN SPUMARETROVIRUS ANTIBODY REACTIVITY IN MULTIPLE-SCLEROSIS

      Journal of neurology
    35. CELLO J; SVENNERHOLM B
      DETECTION OF ENTEROVIRUS-SPECIFIC TOTAL AND POLYMERIC IGA ANTIBODIES IN SERUM - USING A SYNTHETIC PEPTIDE OR HEATED VIRION ANTIGEN IN ELISA

      Journal of medical virology
    36. CELLO J; SAMUELSON A; STALHANDSKE P; SVENNERHOLM B; JEANSSON S; FORSGREN M
      IDENTIFICATION OF GROUP-COMMON LINEAR EPITOPES IN STRUCTURAL AND NONSTRUCTURAL PROTEINS OF ENTEROVIRUSES BY USING SYNTHETIC PEPTIDES (VOL 31, PG 911, 1993)

      Journal of clinical microbiology
    37. GISSLEN M; CHIODI F; FUCHS D; NORKRANS G; SVENNERHOLM B; WACHTER H; HAGBERG L
      MARKERS OF IMMUNE STIMULATION IN THE CEREBROSPINAL-FLUID DURING HIV-INFECTION - A LONGITUDINAL-STUDY

      Scandinavian journal of infectious diseases
    38. FURUTA Y; ERIKSSON K; SVENNERHOLM B; FREDMAN P; HORAL P; JEANSSON S; VAHLNE A; HOLMGREN J; CZERKINSKY C
      INFECTION OF VAGINAL AND COLONIC EPITHELIAL-CELLS BY THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IS NEUTRALIZED BY ANTIBODIES RAISED AGAINST CONSERVED EPITOPES IN THE ENVELOPE GLYCOPROTEIN GP120

      Proceedings of the National Academy of Sciences of the United Statesof America
    39. TRYBALA E; BERGSTROM T; SVENNERHOLM B; JEANSSON S; GLORIOSO JC; OLOFSSON S
      LOCALIZATION OF A FUNCTIONAL SITE ON HERPES-SIMPLEX VIRUS TYPE-1 GLYCOPROTEIN-C INVOLVED IN BINDING TO CELL-SURFACE HEPARAN-SULFATE

      Journal of General Virology
    40. HOLMGREN J; CZERKINSKY C; ERIKSSON K; HAGBERG L; LEBENS M; NORKRANS G; SVENNERHOLM B; VAHLNE A
      STRATEGIES FOR THE INDUCTION OF IMMUNE-RESPONSES AT MUCOSAL SURFACES

      Journal of acquired immune deficiency syndromes
    41. VAHLNE A; HORAL P; HALL WW; RYMO L; CZERKINSKY C; HOLMGREN J; SVENNERHOLM B
      INHIBITION OF HIV-1 REPLICATION BY A NOVEL FAMILY OF SHORT MODIFIED PEPTIDES

      Journal of acquired immune deficiency syndromes
    42. ERIKSSON K; HORAL P; SVENNERHOLM B; JEANSSON S; VAHLNE A; HOLMGEN J; CZERKINSKY C
      SYSTEMATIC IDENTIFICATION OF T-CELL ACTIVATING EPITOPES ON THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN GP120 IN PRIMATES IMMUNIZED WITH SYNTHETIC PEPTIDES

      Vaccine
    43. DISTEFANO M; NORKRANS G; CHIODI F; HAGBERG L; NIELSEN C; SVENNERHOLM B
      ZIDOVUDINE-RESISTANT VARIANTS OF HIV-1 IN BRAIN

      Lancet
    44. ARENDRUP M; SONNERBORG A; SVENNERHOLM B; AKERBLOM L; NIELSEN C; CLAUSEN H; OLOFSSON S; NIELSEN JO; HANSEN JES
      NEUTRALIZING ANTIBODY-RESPONSE DURING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - TYPE AND GROUP SPECIFICITY AND VIRAL ESCAPE

      Journal of General Virology
    45. LYCKE J; SVENNERHOLM B; SVENNINGSSON A; HORAL P; NORDQVISTBRANDT E; ANDERSEN O
      POSSIBLE ASSOCIATION OF HTLV-I INFECTION AND DEMENTIA

      Acta neurologica Scandinavica


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/01/21 alle ore 07:32:23